Health Bulletin 05/September/2026
Here are the top health stories for the day:
NEET UG 2026: MCC Begins Round 2 Counselling With 23,585 Clear, Virtual Vacancies
In a major update for candidates seeking admissions through Round 2 of the NEET UG Counselling 2026, the Medical Counselling Committee (MCC) has released three separate seat matrices covering clear vacancies, virtual vacancies and newly added seats for MBBS, BDS and BSc Nursing courses.
According to the seat matrices, a total of 11,302 clear-vacancy seats and 12,283 virtual-vacancy seats, while another 659 seats have been newly added for Round 2.
For more details, check out the full story on the link mentioned below:
NEET SS 2025: Centre Willing to Return Unfilled Seats to Tamil Nadu, Tells Supreme Court
The Union Government informed the Supreme Court that it has decided to return all unfilled NEET SS 2025 seats to Tamil Nadu, which had been transferred to the All India Quota for counselling.
Additional Solicitor General Aishwarya Bhati on Thursday told a bench of Justice PS Narasimha and Justice Alok Aradhe that the government would also consider reducing the qualifying percentile to help fill the remaining seats. The Centre will inform the court about the extent of the reduction on Tuesday (September 8).
For more details, check out the full story on the link mentioned below:
Delhi HC Grants Relief to 2 Candidates Linked to NEET Paper Leak, Allows Counselling
The Delhi High Court has directed the National Testing Agency (NTA) to declare within 24 hours the NEET 2026 retest results of two candidates whose results were withheld over allegations linked to the paper leak.
The bench observed that they had not been named as accused in the CBI chargesheet.
The petitioners had initially appeared for NEET-UG 2026, conducted on May 3, but the examination was subsequently cancelled following allegations of a question paper leak. They thereafter appeared in the Re-NEET examination. The CBI investigated the alleged leakage and, after completing its probe, filed a chargesheet in which the two petitioners were named as witnesses and not accused.
For more details, check out the full story on the link mentioned below:
Delhi HC orders NTA to release NEET 2026 retest results of 2 candidates names as CBI witnesses
66-year-old Patient Receives Human Kidney Transplant After 271 Days With Pig Kidney
A 66-year-old man who lived for 271 days without dialysis after receiving a genetically edited pig kidney has become the first living recipient to transition from a porcine kidney transplant to a human kidney transplant. Tim Andrews received the pig kidney at Massachusetts General Hospital in January 2025 and later underwent a deceased-donor human kidney transplant in January 2026. The case, published in The Lancet on September 3, marks the longest dialysis-free survival reported after pig-to-human kidney xenotransplantation and provides new evidence for using xenotransplants as a bridge while patients await human organs.
The genetically modified pig kidney initially functioned immediately, although Andrews developed an early episode of T-cell-mediated rejection that responded to treatment. After immunosuppression was reduced because of an infection, the kidney developed microvascular injury and inflammation, eventually leading to organ failure. No pig pathogen transmission was detected. Researchers said the case highlights both the potential of xenotransplantation to address the shortage of donor kidneys and the need to improve genetic engineering, immune-suppression strategies and monitoring to achieve longer-lasting outcomes, according to a Harvard Medical School report.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.